"Regulator orders John Bordynuik to pay a penalty for
"
Regulator orders John Bordynuik to pay a penalty for improper distribution of securities
By James Langton | April 04, 2014 17:25
The Ontario Securities Commission (OSC) has ordered a man to pay a $125,000 penalty and banned him from serving as a director or officer of an issuer for five years in connection with an improper distribution of securities ."
http://www.investmentexecutive.com/-/osc-fine...er-125-000
http://www.osc.gov.on.ca/documents/en/Proceed...nuikjw.pdf
"
SEC CHARGES COMPANY AND ITS OFFICERS WITH ACCOUNTING FRAUD
The Securities and Exchange Commission announced today that it filed an action in federal court in Massachusetts against JBI, Inc., a publicly-traded company formerly located in Massachusetts and now headquartered in Ontario, Canada. The Commission also charged JBI’s current CEO, John Bordynuik, a resident of Ontario, Canada, and its former CFO, Ronald Baldwin, Jr, a resident of Palm Harbor, Florida. The action alleges that the defendants engaged in a scheme to commit securities and accounting fraud by reporting materially false and inaccurate financial information on the financial statements of JBI, Inc. for two reporting periods during 2009.
https://www.sec.gov/litigation/litreleases/2012/lr22220.htm
https://www.sec.gov/litigation/complaints/2012/comp22220.pdf
"
Court Enters Final Judgments Against JBI, Inc. and Former Officer in Accounting Fraud Case "
The Securities and Exchange Commission announced today that a Massachusetts federal court entered final judgments by consent on June 26, 2013 and March 20, 2013, respectively, against John W. Bordynuik (“Bordynuik”) and JBI, Inc. (“JBI”), two defendants in a fraud action filed by the Commission in 2012. The Commission alleged in its complaint that JBI, its then CEO, John Bordynuik, and its former CFO, Ronald Baldwin, Jr. (“Baldwin”), engaged in a scheme to commit securities and accounting fraud in 2009. In the consent judgments, the Court ordered JBI to pay $150,000 and Bordynuik to pay $110,000 in civil monetary penalties.
The Commission filed its action on January 4, 2012, alleging that during two reporting periods in 2009 and in contravention of Generally Accepted Accounting Principles (“GAAP”), JBI stated materially false and inaccurate financial information on its financial statements. The Complaint alleged that the defendants misrepresented and overstated the actual value of certain assets, known as media credits, by almost 1,000%, in an effort to bolster its balance sheet. JBI then used the overvalued financial statements in two private capital raising efforts (Private Investment in Public Equity or PIPES) that raised over $8.4 million from unwitting investors in these PIPES just before the company issued a public statement indicating its financial statements could no longer be relied upon, in part, due to the erroneous valuation of the media credits and other assets on the balance sheet. According to the complaint, Bordynuik was aware of, or was reckless in not being aware of, GAAP concerns surrounding the reported value of the media credits in advance of the company’s periodic reports that included the financial statements filed with the Commission, yet falsely certified that the company’s financial statements for those reporting periods were filed in conformity with GAAP.
Without admitting or denying the allegations in the Commission’s complaint, JBI and Bordynuik consented to final judgments entered by the Court. The final judgment against JBI permanently enjoined the company from violating Section 17(a) of the Securities Act of 1933 (“Securities Act”) and Sections 10(b), 13(a), 13(b)(2)(A), 13(b)(2)(
and 13(b)(5) of the Securities Exchange Act of 1934 (“Exchange Act”) and Rules 10b-5, 12b-20, 13a-1, 13a-11, and 13a-13 thereunder, and ordered JBI to pay a civil monetary penalty of $150,000. The final judgment against Bordynuik permanently enjoined him from violating Section 17(a) of the Securities Act and Sections 10(b) and 13(b)(5) of the Exchange Act and Rules 10b-5, 13a-14, 13b2-1 and 13b2-2 thereunder, and from aiding and abetting violations of Sections 13(a), 13(b)(2)(A), and 13(b)(2)(
of the Exchange Act and Rules 12b-20, 13a-1, and 13a-11, and ordered him to pay a civil penalty of $110,000. Bordynuik also was barred for five years (from March 18, 2013) from acting as an officer or director of a public company. The case against the remaining defendant (Baldwin) remains pending.
https://www.sec.gov/litigation/litreleases/2013/lr22735.htm
Plastic2Oil, Inc. (PTOI) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Unicycive Therapeutics' Rough Ride In this wild market, sometimes even the most seasoned investors get blindsided. Unicycive Therapeutics (NASDAQ: UNC) shareholders are currently caught in a storm with their stock nose-diving by 39.1% on June 30, 2026. It's like being taken to the cleaners without the decency of a warning. Failed Expectations & FDA Blues Here's the...
Continue Reading
When you're eyeing a used work van, don't just kick the tires and jot down the mileage—there's a whole backyard BBQ checklist you need to chew through. Tony Collichio, the work van guru from Spencerport, lays it down for us, highlighting key questions to ask before pulling out the checkbook. And let me tell you, these aren’t your everyday 'how does it drive?' queries....
Continue Reading
Laying Down the Tracks: Essential Foundations in Hockey When it comes to developing youth hockey skills, there's no magic formula or flashy trick that'll make overnight stars out of young players. According to HelloNation's recent piece featuring hockey development expert Dave Maksymiu, it’s all about going back to basics. This seems to be the memo often missed by...
Continue Reading
Ringing the Alarm on Digital Dangers Like trying to herd cats on a wild day at the market, keeping teens safe online is a task as tricky as they come. And now, with over 20,000 parents joining forces, it seems there's a real demand out there for some much-needed consistency in online safeguards across all social media platforms. This isn't just about one platform or...
Continue Reading
AbbVie's Injection Makes Waves in Crohn's Treatment Here's a bit of medicine shake-up for you. AbbVie just snagged FDA approval for its subcutaneous SKYRIZI—specifically designed for adults battling moderately to severely active Crohn's disease. This news isn't just a blip on the radar; it's significant for patients and the healthcare landscape. We're talking about new...
Continue Reading
Battery-Powered Revolution in Louisville The treadmill of lawn care just took a high-tech spin with DCK Tools strutting their stuff at Equip Exposition 2026. Unrolled at the Kentucky Exposition Center, the event from October 21 to 23 was brimming with their battery-powered wares that aim to take the grunt out of yard work. Game-Changing Range of Garden Tools DCK's decked...
Continue Reading
Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...
Continue Reading
Massive Growth and Strategic Investment in DigitalXForce Now here’s a company that’s shaking things up—DigitalXForce. Right on the back of a staggering 514% growth, they’ve corralled a strategic investment from Arsenal Growth Equity. If you blink, you might miss just how fast they’re sprinting through the tech landscape. Institutional Support Backing the...
Continue Reading
Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...
Continue Reading
AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...
Continue Reading
Top 5 Most Recently Viewed Articles
Overview of CRENESSITY™ Approval Neurocrine Biosciences, Inc. announced a significant breakthrough with the FDA's approval of CRENESSITY™ (crinecerfont), marking the first new treatment for classic congenital adrenal hyperplasia (CAH) in nearly seven decades. This innovative therapy represents a profound shift in the management of this serious genetic condition that...
Continue Reading
Solidion's Strategic Withdrawal: Timing or Tactical Move? Solidion Technology, for all intents and purposes, just took a step back. Now, before we wave our hands in panic, let's stew over why the withdrawal of their S-1 registration might actually be more of a tactical retreat than a sign of sinking ship. They're pulling the plug on this specific filing—not because...
Continue Reading
The Promising Growth of the Global Couriers Market The couriers market is on the brink of transformation, with expected growth of USD 115.9 billion from 2024 to 2028. This remarkable expansion is being driven primarily by advancements in technology and the integration of artificial intelligence (AI) in various logistics processes. During this period, the market is...
Continue Reading
Insights Into Private Market Allocations by Advisors A recent survey highlights a transformative trend among investment advisors regarding their allocation strategies. According to the findings by Hamilton Lane, nearly one-third of advisors are aiming to allocate 20% or more of their clients' portfolios to private markets in the near future. This shows a significant...
Continue Reading
Zack Kass: A Visionary Leader in AI Zack Kass, a prominent AI strategist and executive business advisor, is set to be the keynote speaker at the 2026 International Conference & Exposition organized by the Association for Talent Development. This global event, at the Los Angeles Convention Center, is expected to attract thousands of attendees aiming to explore the latest...
Continue Reading